Clincosm LogoSign in Get a demo

carcinoma, squamous cell of head and neck

Showing 1 - 25 of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Squamous Cell of Head and Neck, NSCLC, Ovarian Tumors Trial (disitamab vedotin)

Not yet recruiting
  • Carcinoma, Squamous Cell of Head and Neck
  • +3 more
  • disitamab vedotin
  • (no location specified)
Aug 15, 2023

Disease-free Survival of High-risk Head-neck Cutaneous Squamous

Active, not recruiting
  • Carcinoma, Squamous Cell
  • +5 more
  • Treatment
  • Maastricht, Netherlands
  • +1 more
Apr 26, 2023

Cancer of Head and Neck, Head Neck Cancer, Tumors, Head and Neck Trial in Boston, Saint Louis, New York (biological, procedure,

Active, not recruiting
  • Cancer of Head and Neck
  • +5 more
  • MK-3475 (neoadjuvant)
  • +6 more
  • Boston, Massachusetts
  • +2 more
Dec 9, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in United States (Cetuximab, PD 0332991)

Active, not recruiting
Has Results
  • Carcinoma, Squamous Cell of Head and Neck
  • Cetuximab
  • PD 0332991
  • Atlanta, Georgia
  • +4 more
Nov 1, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in Darmstadt (Cetuximab, Cisplatin/Carboplatin, 5-fluorouracil)

Completed
Has Results
  • Carcinoma, Squamous Cell of Head and Neck
  • Darmstadt, Germany
    Research site
Apr 19, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (Nimotuzumab, Placebo)

Active, not recruiting
  • Carcinoma, Squamous Cell of Head and Neck
  • Bedford Park, Australia
  • +29 more
Apr 4, 2022

Recurrent Head Neck Cancer, Carcinoma, Squamous Cell of Head and Neck Trial in Baltimore, Philadelphia, Pittsburgh

Recruiting
  • Recurrent Head and Neck Cancer
  • Carcinoma, Squamous Cell of Head and Neck
  • Baltimore, Maryland
  • +3 more
Mar 25, 2022

Carcinoma, Squamous Cell of Head and Neck, Oropharynx Squamous Cell Carcinoma Trial in Atlanta, Portland, Pittsburgh (Nivolumab

Active, not recruiting
  • Carcinoma, Squamous Cell of Head and Neck
  • Oropharynx Squamous Cell Carcinoma
  • Nivolumab Injection
  • Radiotherapy (RT)
  • Atlanta, Georgia
  • +2 more
Mar 24, 2022

Head and Neck Tumors, Carcinoma, Squamous Cell of Head and Neck, Metastasis Trial in Hospitalet de Llobregat, Barcelona (VCN-01,

Active, not recruiting
  • Head and Neck Neoplasms
  • +3 more
  • VCN-01
  • Durvalumab
  • Hospitalet de Llobregat, Barcelona, Spain
  • +1 more
Mar 25, 2022

Carcinoma, Squamous Cell of Head and Neck, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in United

Terminated
  • Carcinoma, Squamous Cell of Head and Neck
  • +3 more
  • Coral Gables, Florida
  • +4 more
Mar 1, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in France (Afatinib)

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • Angers, France
  • +10 more
Feb 1, 2022

Carcinoma, Squamous Cell of Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma, Hypopharyngeal Cancer Trial in

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • +5 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 24, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in San Antonio (Docetaxel, Cisplatin, Cetuximab and Bevacizumab (TPE-A) Followed

Active, not recruiting
  • Carcinoma, Squamous Cell of Head and Neck
  • Docetaxel, Cisplatin, Cetuximab and Bevacizumab (TPE-A) Followed by Concurrent Radiation, Cisplatin, Cetuximab and Bevacizumab (XPE-A), surgery
  • San Antonio, Texas
    Cancer Therapy and Research Center at UTHSCSA
Dec 15, 2021

Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (Afatinib, Palbociclib, standard of care)

Recruiting
  • Carcinoma, Squamous Cell of Head and Neck
  • Antwerp, Belgium
  • +35 more
Nov 22, 2021

Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, Carcinoma, Squamous Cell of Head and Neck Trial in Essen

Active, not recruiting
  • Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
  • Carcinoma, Squamous Cell of Head and Neck
  • Essen, Germany
    Essen University Hospital
Nov 25, 2021

Melanoma (Skin), Squamous Cell Carcinoma of the Skin, Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (CV8102,

Active, not recruiting
  • Melanoma (Skin)
  • +3 more
  • CV8102
  • CV8102 + anti-PD-1 therapy
  • Graz, Austria
  • +21 more
Nov 3, 2021

Carcinoma, Squamous Cell, Carcinoma, Squamous Cell of Head and Neck Trial in New York (Intraarterial Cetxuimab (Erbitux))

Terminated
  • Carcinoma, Squamous Cell
  • Carcinoma, Squamous Cell of Head and Neck
  • Intraarterial Cetxuimab (Erbitux)
  • New York, New York
    Lenox Hill Hospital
Oct 27, 2021

Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (CetuGEX™, Cetuximab, Chemotherapy)

Completed
Has Results
  • Carcinoma, Squamous Cell of Head and Neck
  • Antwerp, Belgium
  • +33 more
Oct 4, 2021

Carcinoma, Squamous Cell of Head and Neck Trial in Amsterdam (Blood draw)

Active, not recruiting
  • Carcinoma, Squamous Cell of Head and Neck
  • Blood draw
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek
Aug 3, 2021

Carcinoma, Squamous Cell of Head and Neck Trial in Chapel Hill (AZD1775, Cisplatin, Intensity Modulated Radiotherapy Treatments)

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
Jun 27, 2021

Carcinoma, Squamous Cell of Head and Neck Trial in France (Copanlisib, Cetuximab)

Terminated
  • Carcinoma, Squamous Cell of Head and Neck
  • Angers, France
  • +6 more
Mar 24, 2021

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (PF-05082566, rituximab)

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • +6 more
  • Duarte, California
  • +41 more
Mar 4, 2020

Carcinoma, Squamous Cell of Head and Neck Trial in Amsterdam (avelumab, radiotherapy, cetuximab)

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek
Dec 10, 2019

Carcinoma, Squamous Cell of Head and Neck Trial in United States (VTX-2337, Carboplatin, Cisplatin)

Completed
Has Results
  • Carcinoma, Squamous Cell of Head and Neck
  • Little Rock, Arkansas
  • +52 more
Oct 11, 2019

NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Birmingham, Alabama
  • +10 more
Jul 17, 2019